A ruthenium-based reaction exploits the stronger carbon-deuterium bond to enrich one mirror-image form from a racemic mixture ...

In one of the largest tests to date, researchers find that satellites reliably spot the greenhouse gas across the board ...

HydRegen’s scientists are commercializing hydrogenase systems that work in conventional chemical reactors. Credit: HydRegen Enzymes are powerful tools for chemical synthesis, but their natural setting ...

Over $1 billion sat unused in US National Science Foundation (NSF) accounts as fiscal 2026 came to a close Oct. 1. A White ...

After successfully completing our previous strategic plan, we developed a new strategic plan in 2025. At its heart is our ...

In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium. The group also uses nitrogen-containing molecules to enhance catalytic ...

Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...

Finally, we should be worried about how these trial markets could impact public perception of the drug development and ...

Estuary is now plotting human trials that will begin in 2027 and 2028. The first will test EST-201, a Pkd2 gene therapy for ...

One compound they screened, azo-morphine-3 (AM-3), showed high affinity and high potency for the μ-opioid receptor (MOR).

Mary Jo Ondrechen, a distinguished professor of chemistry, says scientific fields are moving in an exciting direction ...

The US Department of Homeland Security (DHS) has proposed a new rule that would impose fees for international students ...